Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alkermes
Fierce Biotech
Midsize biotechs form coalition to fight against MFN policy
A group of 10 domestic, medium-sized biotechs launched the Midsized Biotech Alliance of America to advocate for free-market solutions to drug policy.
Will Maddox
Feb 25, 2026 1:05pm
With $2.37B offer, Alkermes sweetens deal to acquire Avadel
Nov 19, 2025 9:53am
Despite Alkermes deal, Avadel now prefers Lundbeck's $2.4B offer
Nov 18, 2025 12:40pm
Lundbeck looks to buy Avadel from under Alkermes with $2.25B bid
Nov 14, 2025 9:29am
To enter sleep market, Alkermes forks over $2.1B for Avadel
Oct 22, 2025 12:04pm
Even through its remake, Alkermes retains upward trajectory: CEO
Jan 13, 2025 7:36am
